发明名称 SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF - NMDA
摘要 Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of conditions such as depression and related disorders. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
申请公布号 HK1218417(A1) 申请公布日期 2017.02.17
申请号 HK20160106442 申请日期 2016.06.06
申请人 Aptinyx Inc. 发明人 LOWE, John, A., III;KHAN, M., Amin
分类号 C07D;A61K;A61P 主分类号 C07D
代理机构 代理人
主权项
地址